Journal for ImmunoTherapy of Cancer (Nov 2021)
Fc-comprising scDb-based trivalent, bispecific T-cell engagers for selective killing of HER3-expressing cancer cells independent of cytokine release
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2021)